Anavip

ANAVIP is the trade name of a snake antivenin indicated for the management of adult and pediatric patients with North American rattlesnake envenomation. As defined by the FDA, the proper name is crotalidae immune F(ab')2 (equine). It is manufactured by Instituto Bioclon for Rare Disease Therapeutics in the United States.

Anavip

ANAVIP is the trade name of a snake antivenin indicated for the management of adult and pediatric patients with North American rattlesnake envenomation. As defined by the FDA, the proper name is crotalidae immune F(ab')2 (equine). It is manufactured by Instituto Bioclon for Rare Disease Therapeutics in the United States.